Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents
oleh: Li Su, Ye Tu, De-pei Kong, Da-gui Chen, Chen-xi Zhang, Wan-nian Zhang, Chun-lin Zhuang, Zhi-bin Wang
Format: | Article |
---|---|
Diterbitkan: | Elsevier 2020-11-01 |
Deskripsi
Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) has been widely spread in the world with a high mortality. Cytokine storm syndrome (CSS) and acute lung injury caused by SARS-CoV-2 infection severely threaten the patients. With the purpose to find effective and low-toxic drugs to mitigate CSS, entecavir and imipenem were identified to reduce TNF-α using a LPS-induced macrophage model from the anti-infective drug library. Entecavir and imipenem efficiently suppressed the release of inflammatory cytokines by partly intervention of NF-κB activity. The acute lung injury was also alleviated and the survival time was prolonged in mice. In addition, entecavir and imipenem inhibited the release of TNF-α and IL-10 in human peripheral blood mononuclear cells (hPBMCs). Collectively, we proposed that entecavir and imipenem might be candidates for the treatment of CSS.